Cited by 973BRCA gene mutations in cancerWomen's cancer prevention and managementBreast Lesions and Carcinomas

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation

Open access

Meijers-Heijboer, Hanne, van Geel, Bert, van Putten, Wim L.J., Henzen-Logmans, Sonja C., Seynaeve, Caroline, Menke-Pluymers, Marian B.E., Bartels, Carina C.M., Verhoog, Leon C., van den Ouweland, Ans M.W., Niermeijer, Martinus F., Brekelmans, Cecile T.M., Klijn, Jan G.M.·2001·New England Journal of Medicine

DOI 10.1056/nejm200107193450301

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Women with a BRCA1 or BRCA2 mutation have a high risk of breast cancer and may choose to undergo prophylactic bilateral total mastectomy. We investigated the efficacy of this procedure in such women. METHODS: We conducted a prospective study of 139 women with a pathogenic BRCA1 or BRCA2 mutation who were enrolled in a breast-cancer surveillance program at the Rotterdam Family Cancer Clinic. At the time of enrollment, none of the women had a history of breast cancer. Seventy-six of these women eventually underwent prophylactic mastectomy, and the other 63 remained under regular surveillance. The effect of mastectomy on the incidence of breast cancer was analyzed by the Cox proportional-hazards method in which mastectomy was modeled as a time-dependent covariate. RESULTS: No cases of breast cancer were observed after prophylactic mastectomy after a mean (+/-SE) follow-up of 2.9+/-1.4 years, whereas eight breast cancers developed in women under regular surveillance after a mean follow-up of 3.0+/-1.5 years (P=0.003; hazard ratio, 0; 95 percent confidence interval, 0 to 0.36). The actuarial mean five-year incidence of breast cancer among all women in the surveillance group was 17+/-7 percent. On the basis of an exponential model, the yearly incidence of breast cancer in this group was 2.5 percent. The observed number of breast cancers in the surveillance group was consistent with the expected number (ratio of observed to expected cases, 1.2; 95 percent confidence interval, 0.4 to 3.7; P=0.80). CONCLUSIONS: In women with a BRCA1 or BRCA2 mutation, prophylactic bilateral total mastectomy reduces the incidence of breast cancer at three years of follow-up.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm200107193450301

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M. T., Cronin, W. M., Vogel, V. G., Robidoux, A., Dimitrov, N. S., Atkins, J. N., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,450
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
Ford, D., Easton, D., Stratton, M. R., Narod, S., Goldgar, D., Devilee, P., Bishop, D., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · American Journal of Human Genetics · doi:10.1086/301749 · Cited by 2,766
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
Struewing, J., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,399
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400201 · Cited by 1,428
Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: II. BRCA1 and BRCA2
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., et al. (1996) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.275.24.1885 · Cited by 840
BRCA1 Testing in Families With Hereditary Breast-Ovarian Cancer
Lerman, C. E. (1996) · JAMA · doi:10.1001/jama.1996.03530480027036 · Cited by 826
Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
Rebbeck, T. R., Levin, A. M., Eisen, A. F., Snyder, C., Watson, P. A., Cannon‐Albright, L., Isaacs, C. J., Olopade, O., Garber, J. E., Godwin, A. K., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1475 · Cited by 670

Show all 33 references

Research works printed but not linked: 4

Whittemore AS, 1997, Am J Hum Genet, 60, 496
Hartmann LC, 2000, Proc Am Assoc Cancer Res, 41, 222
Kriege M, 2000, Eur J Cancer, 36, S137
Zion SM, 2000, Prog Proc Am Soc Clin Oncol, 19, 441a

Sorted by citations

Items 601–700 of 970

Unilateral vs Bilateral Transoral Robotic Surgery for HPV-Positive Tonsillar Squamous Cell Carcinoma
Peterson, A. M., Bockover, S. R., Kallogjeri, D., Chang, K. W.-L., Tharakan, T., Harbison, R. A., Zolkind, P., Rich, J. T., Pipkorn, P. J., Paniello, R. C., et al. (2025) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2025.1833 · Cited by 5
New insights into the prevention and treatment of familial breast cancer
Euhus, D. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21664 · Cited by 5
Feelings of Women With Strong Family Histories Who Subsequent to Their Breast Cancer Diagnosis Tested BRCA Positive
Joseph, M., Rab, F. A., Panabaker, K., & Nisker, J. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000403 · Cited by 5
The genetics of breast and ovarian cancer IV: a model of breast cancer progression
Lu, B., Macdonald, A. S., & Waters, H. R. (2010) · Scandinavian Actuarial Journal · doi:10.1080/03461238.2010.482188 · Cited by 5
What options for treatment of hereditary breast cancer?
Narod, S. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08465-9 · Cited by 5
Genetic counseling and testing for Li-Fraumeni syndrome: the medical and psychosocial implications
Vogel, K. J., & Shannon, K. (2009) · Community Oncology · doi:10.1016/s1548-5315(11)70360-6 · Cited by 5
Nipple-Sparing Mastectomy: To Spare Or Not To Spare?
Chiba, A., Jakub, J. W., & Hieken, T. J. (2016) · Current Surgery Reports · doi:10.1007/s40137-016-0138-1 · Cited by 5
“There are several series of BRCA1/ 2 patients undergoing NSMs for risk reduction and therapeutic indications showing very low rates of subsequent breast cancer development [31, 34, 35].”
Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan
Yoshimura, A., Okumura, S., Sawaki, M., Hattori, M., Ishiguro, J., Adachi, Y., Kotani, H., Gondo, N., Kataoka, A., Iwase, M., et al. (2018) · Breast Cancer · doi:10.1007/s12282-018-0850-z · Cited by 5
The Importance of Risk-Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) Carriers: A Case Report
Ochaney, P., Patel, K., Haq, F. U., Reese, R., & Igel, S. (2019) · Cureus · doi:10.7759/cureus.5311 · Cited by 5
“In order to prevent such circumstances, risk-reducing bilateral prophylactic mastectomy should be considered as this procedure has been shown to decrease the incidence of breast cancer by 90% in high-risk BRCA carriers [5].”
BackgroundInfluential
Concurrent Prophylactic Mastectomy, Immediate Reconstruction, and Salpingo-Oophorectomy in High-Risk Patients: A Case Series
D’Abbondanza, J. A., George, R., Kives, S. L., & Musgrave, M. A. (2020) · Plastic Surgery · doi:10.1177/2292550320928551 · Cited by 5
Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer
Wan, Q., Hu, L., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., Xu, Y., & Xie, Y. (2020) · Familial Cancer · doi:10.1007/s10689-020-00202-4 · Cited by 5
A global ethics approach to vulnerability
Macklin (2012) · International Journal of Feminist Approaches to Bioethics · doi:10.2979/intjfemappbio.5.2.64 · Cited by 5
Breast
(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00029-5 · Cited by 5
Secondary persistent infection with hepatitis C virus: a challenge for adaptive immunity
Grant, M. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08466-0 · Cited by 5
The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View
Narod, S. A. (2004) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-2-1-5 · Cited by 5
Genetic Factors
Schrader, K. A., Sharaf, R., Alanee, S. R., & Offit, K. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00012-6 · Cited by 5
Effects and Costs of Breast Cancer screening in women with a familial or genetic predisposition
Rijnsburger, R. (2005) · Cited by 5
Preemptive surgery
McAuliffe, P. F., & Cance, W. G. (2006) · Surgery · doi:10.1016/j.surg.2006.01.009 · Cited by 5
Prophylaktische Chirurgie des Mamma- und Ovarialkarzinoms
Lux, M. P., Bani, M. R., Fasching, P. A., & Beckmann, M. W. (2005) · Der Chirurg · doi:10.1007/s00104-005-1100-4 · Cited by 5
Why not to screen high-risk women anticipating BRCA1/BRCA2 testing for psychological distress.
Benazon, N. R., Coyne, J. C., Calzone, K. A., & Weber, B. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.70.1.258 · Cited by 5
Re: Risk-Reduction Mastectomy: Clinical Issues and Research Needs
Evans, D. G., Howell, A., Baildam, A. D., Brain, A., Lalloo, F. I., & Hopwood, P. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.307 · Cited by 5
Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?
Kotsopoulos, J., & Narod, S. A. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1424547 · Cited by 5
eTumorRisk, an algorithm predicts cancer risk based on comutated gene networks in an individual’s germline genomePreprint
Zou, J., & Wang, E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/393090 · Cited by 5
“For example, bilateral prophylactic mastectomy can reduce the risk of developing breast cancer by > 95% in women with BRCA1/2 mutations and by up to 90% in women who have a strong family history ([24, 25] and https://www.”
Background
Precision Prevention: The Current State and Future of Genomically Guided Cancer Prevention
Kassem, N., Stout, L. A., Hunter, C., Schneider, B., & Radovich, M. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00278 · Cited by 5
Genetic Counselling, Testing, and Management of Hereditary Breast and Ovarian Cancer Syndrome in India: Updated Expert Consensus Recommendations from Indian Society of Medical and Pediatric Oncology
Malhotra, H., Pramanik, R., Srinivas, S., Kotwal, P., Mehra, N., Gupta, S., Rajkumar, T., Sarin, R., Babu, G., Bapna, A., et al. (2025) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0044-1788727 · Cited by 4
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery
Irelli, A., Patruno, L. V., Ranieri, S. C., Giacomo, D. D., Malatesta, S., Alesse, E., Tessitore, A., & Cannita, K. (2024) · Biomedicines · doi:10.3390/biomedicines12040714 · Cited by 4
Impact on Global Health Status, Quality-Sexual Life and Chronic Fatigue State of Risk-Reducing Salpingo-Oophorectomy in Women Who Are BRCA1/2 Mutation Carriers: Experience from a Third-Level Italian Center
Corte, L. D., Palumbo, M., Ascione, M., D'Angelo, G., Verde, M. L., Ferrari, F., Morra, I., & Bifulco, G. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000543869 · Cited by 4
Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
Gurjar, N., Basit, A., Thomson, C., & Kirby, R. M. (2012) · Journal of Surgical Case Reports · doi:10.1093/jscr/2012.10.2 · Cited by 4
“Clear resection margins are not required following surgery for LCIS alone (3,4).”
Background
Breast Cancer Gene, BRCA1 and BRCA2
Choi, D. H. (2003) · Journal of Breast Cancer · doi:10.4048/jkbcs.2003.6.2.45 · Cited by 4
Breast Cancer Prevention in BRCA1/2 Mutation Carriers: A Qualitative Review
Fuller, S. N., Liebens, F., Carly, B., Pastijn, A., & Rozenberg, S. (2008) · The Breast Journal · doi:10.1111/j.1524-4741.2008.00661.x · Cited by 4
Maximizing Benefits and Minimizing Risks in the Primary Prevention of Schizophrenia
DeVylder, J. (2014) · Social Work · doi:10.1093/sw/swu027 · Cited by 4
Hereditary Breast and Ovarian Cancer
Lux, M. P., Bani, M. R., Fasching, P. A., & Beckmann, M. W. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_26 · Cited by 5
Breast Cancer Genetics
Lynch, H. T., Marcus, J. N., Lynch, J. A., Snyder, C., & Rubinstein, W. S. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5221-0.00021-8 · Cited by 4
Adjustment Issues Related to Bilateral Prophylactic Mastectomy in Women at Elevated Risk of Developing Breast Cancer
Fuller, S. L., & Anderson, R. C. (2006) · Plastic and Aesthetic Nursing · doi:10.1097/00006527-200604000-00004 · Cited by 4
Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting
Aristei, C., Bölükbaşı, Y., Kaidar‐Person, O., Pfeffer, R., Arenas, M., Boersma, L. J., Ciabattoni, A., Coles, C. E., Franco, P., Krengli, M., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103774 · Cited by 4
Report from the OECI Oncology Days 2014
van Harten, W. (2014) · ecancermedicalscience · doi:10.3332/ecancer.2014.496 · Cited by 4
MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER
Laptiev, S. A., Korzhenevskaia, M. A., Соколенко, А. П., Iyevleva, A. G., & Имянитов, Е. Н. (2018) · The Scientific Notes of the Pavlov University · doi:10.24884/1607-4181-2018-25-2-7-18 · Cited by 4
“Контралатеральная профилактическая МЭ может быть показана носительницам мутаций в генах BRCA1/2 с РМЖ, особенно диагностированным в молодом возрасте, и односторонней МЭ в анамнезе [24, 33].”
Expectations of Surveillance for Non-BRCA Gene Mutation Carriers at Increased Risk for Breast Cancer
Caskey, R., Singletary, B. A., Ayre, K., Parker, C. C., Krontiras, H., & Lancaster, R. B. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.06.029 · Cited by 5
Familial Breast Cancer: Detection of Prevalent High-Risk Epithelial Lesions
Bult, P., & Hoogerbrugge, N. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8369-3_6 · Cited by 4
Cancer screening and genetic counseling
Brunet, J., & Pérez‐Segura, P. (2004) · Clinical & Translational Oncology · doi:10.1007/bf02710121 · Cited by 4
Preoperative Risk Assessment Among Women Undergoing Bilateral Prophylactic Mastectomy for Cancer Risk Reduction
Rueth, N. M., McMahon, M., Arrington, A. K., Swenson, K. K., Leach, J. W., & Tuttle, T. M. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1642-2 · Cited by 4
Magnetic Resonance Galactography: a Feasibility Study in Women with Prior Atypical Breast Duct Cytology
Kurian, A. W., Hartman, A., Mills, M. A., Logan, L. J., Sawyer, A. M., Ford, J. M., & Daniel, B. L. (2008) · The Breast Journal · doi:10.1111/j.1524-4741.2007.00562.x · Cited by 4
Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history
Kwong, A., Chu, A. T.-W., Wu, C. T.-S., & Tse, D. M.-S. (2014) · Familial Cancer · doi:10.1007/s10689-014-9706-7 · Cited by 4
“Others may opt for more radical and invasive surgical prevention such as prophylactic mastectomy [25, 26] and salpingo-oophorectomy to remove the main BRCA-targeted organs (breasts and ovaries) before the diseases clinically develop [27–29].”
Background
Inadequate Family History Assessment by Oncologists is an Important Physician Barrier to Referral for Hereditary Breast Cancer Evaluation
Ow, S. G. W., Yong, Y., Chieng, W.-S., Phyu, P. S., & Lee, S.-C. (2014) · Clinical Oncology · doi:10.1016/j.clon.2013.11.029 · Cited by 4
Psychological factors that influence decision making about prophylactic surgery
Fang, C. Y., Mckenzie, T., Miller, S. M., & Daly, M. B. (2005) · Complutensian Scientific Journals (Complutense University of Madrid) · doi:10.5209/rev_psic.2005.v2.n2.16890 · Cited by 4
Management of Women at High Familial Risk of Breast and Ovarian Cancer
Field, K., & Phillips, K. (2009) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848163652_0039 · Cited by 4
Clinical Relevance of Hereditary Ovarian Cancer
Lancaster, J. M. (2008) · CRC Press eBooks · doi:10.3109/9781420052886-2 · Cited by 4
Beratung junger Frauen mit hereditärer Belastung für Brust- und Eierstockkrebs
Schmutzler, R. K., & Rhiem, K. (2017) · Forum · doi:10.1007/s12312-017-0212-3 · Cited by 4
“die Gesamtmortalität (PBSO) bei gesunden BRCAMutationsträgerinnen [3, 10].”
Recommendations for the surveillance of young women at increased risk for breast cancer
Hadden, W. E. (2007) · Australasian Radiology · doi:10.1111/j.1440-1673.2006.01645.x · Cited by 4
Early Detection of Cancer
Hennessy, B. T., Bast, R. C., Gonzalez-Angulo, A. M., & Mills, G. B. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10025-1 · Cited by 4
The Role of Estrogens in BRCA1/2 Mutation Carriers
de Carvalho, M., Jenkins, J., Nehrebecky, M. E., & Lahl, L. L. (2003) · Cancer Nursing · doi:10.1097/00002820-200312000-00001 · Cited by 4
“The only prospective study completed on BRCA1/2 carriers was published in 2001.(58) This was a surveillance study where 76 women chose to undergo prophylactic mastectomy and 63 women chose regular surveillance.”
Background
Inherited Risk of Women's Cancers: What's Changed for the Practicing Physician?
FRANK, T. S., & Critchfield, G. C. (2002) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200209000-00011 · Cited by 4
“In two major studies, not a single breast cancer has been observed after prophylactic mastectomy among any of the study participants with such mutations.(38,39) Because of the efficacy of surveillance in detecting most early-stage breast cancers, and the high cure rate of breast cancers detected at an early stage, pro…”
Background
Breast-Cancer Genomics
Friedenson, B. (2003) · New England Journal of Medicine · doi:10.1056/nejm200308283490918 · Cited by 4
Current insights into breast and ovarian cancer risk: a contemporary review
Gaughan, N. A., Rademacher, N., ROGERS, C., Purdy, A. C., Mattingly, J. D., PATTEN, C. R., Cobb, A. N., Kong, A. L., & Cortina, C. S. (2025) · Minerva Surgery · doi:10.23736/s2724-5691.25.10651-5 · Cited by 3
Sentinel Lymph Node Biopsy for Prophylactic Mastectomy: Necessary Precaution or Unnecessary Procedure?
Shern, T. P., Holt, L. R., Chamberlain, V., Gadd, M. A., Kwait, R. M., Verdial, F. C., Specht, M. C., Smith, B. L., & Özmen, T. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-18814-4 · Cited by 3
Prévention des cancers du sein : de la chimioprévention à la chirurgie prophylactique
Morcel, K., Rouquette, S., Dugast, C., Bendavid, C., Audrain, O., & Lévêque, J. (2008) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2008.05.013 · Cited by 3
Breast Cancer Genetics
O’Donnell, M., Axilbund, J. E., & Euhus, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00017-9 · Cited by 5
The genetics of breast cancer, risk-reducing surgery and prevention
Evans, D. G., Kwong, A., & Baildam, A. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-7020-4959-0.00008-4 · Cited by 3
Teamwork in Breast Cancer Surgery: Factors Affecting Success Rate and Increasing Success Rate in the Operating Room
Gürdal, S. Ö., Açar, S., & Cantürk, N. Z. (2021) · Springer eBooks · doi:10.1007/978-3-030-73147-2_22 · Cited by 3
Counselling of path_ BRCA carriers who are considering risk-reducing oophorectomy
Manley, K., Ryan, N. A. J., Jenner, A., Newton, C. L., & Hillard, T. (2023) · Post Reproductive Health · doi:10.1177/20533691231156640 · Cited by 3
Consenso mexicano de cáncer mamario. Manejo del cáncer de mama temprano
Bargalló‐Rocha, E., Aguilar-Villanueva, S., Ahumada-Pámanes, C., Arce-Salinas, C., Álvarez‐Cano, A., Baley-Spindel, I., Bautista‐Piña, V., Cervantes-Sánchez, G., Chávez‐MacGregor, M., Esparza-Arias, N., et al. (2024) · Gaceta Mexicana de Oncología · doi:10.24875/j.gamo.m24000261 · Cited by 3
Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study
Walsh, E. M., Farrell, M., Nolan, C., Gallagher, F., Clarke, R., McCaffrey, J., Kennedy, M. J., Barry, M., Kell, M., & Gallagher, D. (2016) · Irish Journal of Medical Science · doi:10.1007/s11845-015-1267-8 · Cited by 3
“Other international studies report rates of interval breast cancers between 2 and 50 % [11, 12].”
Background
Cancer Anxiety Mediates the Association Between Satisfaction With Medical Communication and Psychological Quality of Life After Prophylactic Bilateral Salpingo-Oophorectomy
Zarbo, C., Brugnera, A., Frigerio, L., Celi, C., Compare, A., Dessì, V., Giordano, R., Malandrino, C., Sina, F. P., Strepparava, M. G., et al. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.840931 · Cited by 3
Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer
Bayraktar, S., Qiu, H., Liu, D., Shen, Y., Gutierrez‐Barrera, A. M., Arun, B., & Şahin, A. A. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s29716 · Cited by 3
Indications et efficacité de la chirurgie prophylactique des cancers gynécologiques et digestifs avec prédisposition génétique
Noguès, C., & Mouret‐Fourme, E. (2012) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31707-8 · Cited by 3
Issues related to advances and controversies in breast cancer management: A multicultural experience
Dobke, M. K., El-Khatib, H. A., & Al-Basti, H. B. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.07.008 · Cited by 3
Should we use MRI to screen women at high-risk of breast cancer?
Gilbert, F. J. (2005) · Cancer Imaging · doi:10.1102/1470-7330.2005.0022 · Cited by 3
“4 years followup in the surveillance group but no cancers were found in the prophylactic mastectomy group [56].”
Background
Aspectos técnicos y resultados de la mastectomía profiláctica en pacientes con elevado riesgo de cáncer de mama
Güemes, A., Sousa, R., Navarro, A., Val-Carreres, P., Moros, M., Sainz, J. M., Mayordomo, J. I., Andrés, R., Polo, E., Álvarez, I., et al. (2004) · Cirugía Española · doi:10.1016/s0009-739x(04)78940-x · Cited by 3
Can Genomics Deliver on the Promise of Improved Outcomes and Reduced Costs?
Williams, M. S. (2003) · Disease Management & Health Outcomes · doi:10.2165/00115677-200311050-00001 · Cited by 3
Modalités de dépistage radiologique devant un risque familial identifié de cancer du sein
Colin, C., & Prince, V. (2007) · Imagerie de la Femme · doi:10.1016/s1776-9817(07)92168-9 · Cited by 3
Genetic Testing for BRCA Mutations Can Save Lives
Yen, T. W. F. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.57 · Cited by 3
Genetic Predisposition to Breast Cancer and Genetic Counseling and Testing
Ready, K. J., & Arun, B. (2007) · Springer eBooks · doi:10.1007/978-0-387-34952-7_3 · Cited by 3
Hormone replacement and breast cancer
Castiglione‐Gertsch, M. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh938 · Cited by 3
The Genetics of Breast and Gynecologic Cancers
Wilbur, J. S., Rojan, A. A., & Legare, R. D. (2007) · Elsevier eBooks · doi:10.1016/b978-032303247-6.10003-6 · Cited by 3
Bilateral mastectomy and the retreat from breast-conserving surgery
Moffat, F. L., & Yakoub, D. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3909-6 · Cited by 4
“[62] BRCA? 76 BPM 63 Surveillance 3 years 0/76”
RISK-REDUCING SALPINGO-OOPHORECTOMY IN WOMEN WITH A BRCA1 OR BRCA2 MUTATION
Oah, N., Auff, D. K., Atagopan, J. A. M. S., Obson, M. A. E. R., Cheuer, L. A. S., Ensley, M. A. H., Udis, C. L. A. H., Athan, N., Llis, A. E., Oyd, J. E. B., et al. (2002) · Cited by 3
Prise en charge du cancer du sein infiltrant de la femme non ménopausée
(2009) · ONCOLOGIE · doi:10.1007/s10269-009-1818-6 · Cited by 3
Gene screening and prevention of hereditary breast cancer
Klijn, J. G. M., & Meijers-Heijboer, H. E. J. (2003) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(03)00005-3 · Cited by 3
“During the 3 years of follow-up in our study, there was one death due to breast cancer [68].”
BackgroundMethodResultInfluentialSelf-citation
Cancer genetics or cancer genomics in the era of genomic medicine?
Daly, P. A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg743 · Cited by 3
“In recent years a number of studies have proven the efficacy of prophylactic mastectomy for women who are at high-risk, including BRCA mutation carriers [29, 30].”
Background
Ethical, Legal, and Social Implications
Riper, M. L. V. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_9 · Cited by 3
Risk assessment and management
Evans, D. G. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-2774-1.00024-4 · Cited by 3
"Getting on with it": New Zealand Women's Experiences of Living with an Increased Risk of Breast and Ovarian Cancer
McEwen, A. (2011) · Otago University Research Archive (University of Otago) · Cited by 3
Breast Cancer Prevention
Kaklamani, V., & O'Regan, R. M. (2002) · American Journal of Cancer · doi:10.2165/00024669-200201030-00002 · Cited by 3
Editor's Comment: Questions Raised by BRCA1/2 -Carrier Screening Programs
Gilbert, F. (2002) · Genetic Testing · doi:10.1089/10906570260199302 · Cited by 3
Serum Proteomics for BRCA1-associated Breast Cancer
Meric‐Bernstam, F. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.08.909 · Cited by 3
Kjemoprevensjon av munnhulekreft
Sudbø, J. (2003) · Den norske tannlegeforenings Tidende · doi:10.56373/2003-07-2 · Cited by 3
Pattern Anlysis of Risk-Reducing Strategies in Unaffected Korean BRCA1/2 Mutation Carriers
Kim, D., Ryu, J. M., Han, S., Kim, Z., & Kim, S. (2024) · Current Oncology · doi:10.3390/curroncol31110499 · Cited by 2
Refining BRCA1 and BRCA2 penetrance estimates in the clinic
Domchek, S. M. (2009) · Current Breast Cancer Reports · doi:10.1007/s12609-009-0018-0 · Cited by 2
Counterpoint: Angelina's choice-or the choice of anyone else in her place
Parikh, P. (2014) · South Asian Journal of Cancer · doi:10.4103/2278-330x.126534 · Cited by 2
Identification and management of women with a family history of breast cancer: Practical guide for clinicians.
Heisey, R., & Carroll, J. C. (2016) · PubMed Central · Cited by 13
Randomized Controlled Trials in Hereditary Cancer Syndromes
Ramamurthy, C., Chertock, Y., & Hall, M. J. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.05.011 · Cited by 2
Engaged Philosophy
Schotch, P. Κ., & Sherwin, S. (2006) · University of Toronto Press eBooks · doi:10.3138/9781442684294 · Cited by 2
RESPONSE: Re: Risk-Reduction Mastectomy: Clinical Issues and Research Needs
Stefanek, M. E., Hartmann, L. C., & Nelson, W. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.307-a · Cited by 2
Secuelas de mastectomía subcutánea profiláctica: caso clínico
Gutiérrez Gómez, C., León, B. R., & Mejía, A. C. (2008) · Cirugía Plástica Ibero-Latinoamericana · doi:10.4321/s0376-78922008000400007 · Cited by 2
Genetics for the General Internist
Laukaitis, C. M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.034 · Cited by 2
“Risk-reducing surgical options include bilateral modified radical mastectomy which can be followed by reconstructive surgery and reduces breast cancer risk by 90%[25–27].”
Background
Contribuição do patologista cirúrgico para o diagnóstico das síndromes do câncer hereditário e avaliação dos tratamentos cirúrgicos profiláticos
Alvarenga, M., Cotta, A., Dufloth, R. M., & Schmitt, F. C. (2003) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442003000200013 · Cited by 2
The Role of DNA Testing in Breast, Ovarian, and Colon Cancers
Friedrich, C. A. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200303000-00004 · Cited by 2
Dépistage du cancer du sein par IRM chez les femmes porteuses d’une mutation génétique
Daguet, E., Malhaire, C., Hardit, C., Athanasiou, A., Khoury, C. E., Thibault, F. E., Ollivier, L., Tardivon, A. A., & Tardivon, A. A. (2008) · Journal de Radiologie · doi:10.1016/s0221-0363(08)73784-3 · Cited by 2
Principes de la chirurgie oncoplastique et de la reconstruction mammaire immédiate après mastectomie pour carcinome ou mastectomie prophylactique
Cothier-Savey, I., & Rimareix, F. (2012) · EMC - Techniques chirurgicales - Chirurgie plastique reconstructrice et esthétique · doi:10.1016/s1286-9325(12)56411-3 · Cited by 2
Risk-reduction surgery in BRCA mutation carriers in a Spanish population: adherence and results
Segura, P. P., Jiménez, P., Olivera, H., Conejero, R. A., Caldés, T., de la Hoya, M., Román, J. M. S. S., Moreno, A., Puente, J., & Díaz‐Rubio, E. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0267-9 · Cited by 2

Authors: Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., Brekelmans, C. T. M., & Klijn, J. G. M.
Affiliations: Erasmus MC (NL)
ORCID: Meijers-Heijboer, Hanne
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2001-07-19
Volume: 345
Issue: 3
Pages: 159-164
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200107193450301
OpenAlex: W2046809735
Cited by: 973
References: 33
Citations by year: 2026: 15 · 2025: 14 · 2024: 14 · 2023: 18 · 2022: 18 · 2021: 24 · 2020: 23 · 2019: 30 · 2018: 21 · 2017: 37 · 2016: 42 · 2015: 28 · 2014: 34 · 2013: 29 · 2012: 42
FWCI: 35.85
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (acceptedVersion, other-oa)
RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
Pure Amsterdam UMC (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Keywords: breast cancer, bilateral prophylactic mastectomy, BRCA1 mutation, BRCA2 mutation, hereditary breast cancer, breast cancer incidence, breast cancer surveillance, genetic susceptibility to cancer
MeSH terms: Adult, Breast Neoplasms, Female, Humans, Middle Aged, Mutation, Neoplasm Proteins, Prospective Studies, Transcription Factors, Mastectomy, Simple, Proportional Hazards Models, Genes, BRCA1, BRCA2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks